Request for Covid-19 Impact Assessment of this Report
The United States Rilpivirine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Rilpivirine market, reaching US$ million by the year 2028. As for the Europe Rilpivirine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Rilpivirine players cover Janssen Cilag International, Gilead Sciences , ViiV Healthcare, and Strides Pharma Science Limited, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Rilpivirine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Self-production API
Outsourcing of API
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Clinic
Drug Center
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Janssen Cilag International
Gilead Sciences
ViiV Healthcare
Strides Pharma Science Limited
Pharmacare Limited
Aspen
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Rilpivirine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Rilpivirine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Rilpivirine by Country/Region, 2017, 2022 & 2028
2.2 Rilpivirine Segment by Type
2.2.1 Self-production API
2.2.2 Outsourcing of API
2.3 Rilpivirine Sales by Type
2.3.1 Global Rilpivirine Sales Market Share by Type (2017-2022)
2.3.2 Global Rilpivirine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Rilpivirine Sale Price by Type (2017-2022)
2.4 Rilpivirine Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Drug Center
2.4.4 Other
2.5 Rilpivirine Sales by Application
2.5.1 Global Rilpivirine Sale Market Share by Application (2017-2022)
2.5.2 Global Rilpivirine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Rilpivirine Sale Price by Application (2017-2022)
3 Global Rilpivirine by Company
3.1 Global Rilpivirine Breakdown Data by Company
3.1.1 Global Rilpivirine Annual Sales by Company (2020-2022)
3.1.2 Global Rilpivirine Sales Market Share by Company (2020-2022)
3.2 Global Rilpivirine Annual Revenue by Company (2020-2022)
3.2.1 Global Rilpivirine Revenue by Company (2020-2022)
3.2.2 Global Rilpivirine Revenue Market Share by Company (2020-2022)
3.3 Global Rilpivirine Sale Price by Company
3.4 Key Manufacturers Rilpivirine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rilpivirine Product Location Distribution
3.4.2 Players Rilpivirine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Rilpivirine by Geographic Region
4.1 World Historic Rilpivirine Market Size by Geographic Region (2017-2022)
4.1.1 Global Rilpivirine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Rilpivirine Annual Revenue by Geographic Region
4.2 World Historic Rilpivirine Market Size by Country/Region (2017-2022)
4.2.1 Global Rilpivirine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Rilpivirine Annual Revenue by Country/Region
4.3 Americas Rilpivirine Sales Growth
4.4 APAC Rilpivirine Sales Growth
4.5 Europe Rilpivirine Sales Growth
4.6 Middle East & Africa Rilpivirine Sales Growth
5 Americas
5.1 Americas Rilpivirine Sales by Country
5.1.1 Americas Rilpivirine Sales by Country (2017-2022)
5.1.2 Americas Rilpivirine Revenue by Country (2017-2022)
5.2 Americas Rilpivirine Sales by Type
5.3 Americas Rilpivirine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rilpivirine Sales by Region
6.1.1 APAC Rilpivirine Sales by Region (2017-2022)
6.1.2 APAC Rilpivirine Revenue by Region (2017-2022)
6.2 APAC Rilpivirine Sales by Type
6.3 APAC Rilpivirine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Rilpivirine by Country
7.1.1 Europe Rilpivirine Sales by Country (2017-2022)
7.1.2 Europe Rilpivirine Revenue by Country (2017-2022)
7.2 Europe Rilpivirine Sales by Type
7.3 Europe Rilpivirine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Rilpivirine by Country
8.1.1 Middle East & Africa Rilpivirine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Rilpivirine Revenue by Country (2017-2022)
8.2 Middle East & Africa Rilpivirine Sales by Type
8.3 Middle East & Africa Rilpivirine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rilpivirine
10.3 Manufacturing Process Analysis of Rilpivirine
10.4 Industry Chain Structure of Rilpivirine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rilpivirine Distributors
11.3 Rilpivirine Customer
12 World Forecast Review for Rilpivirine by Geographic Region
12.1 Global Rilpivirine Market Size Forecast by Region
12.1.1 Global Rilpivirine Forecast by Region (2023-2028)
12.1.2 Global Rilpivirine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Rilpivirine Forecast by Type
12.7 Global Rilpivirine Forecast by Application
13 Key Players Analysis
13.1 Janssen Cilag International
13.1.1 Janssen Cilag International Company Information
13.1.2 Janssen Cilag International Rilpivirine Product Offered
13.1.3 Janssen Cilag International Rilpivirine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Janssen Cilag International Main Business Overview
13.1.5 Janssen Cilag International Latest Developments
13.2 Gilead Sciences
13.2.1 Gilead Sciences Company Information
13.2.2 Gilead Sciences Rilpivirine Product Offered
13.2.3 Gilead Sciences Rilpivirine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Gilead Sciences Main Business Overview
13.2.5 Gilead Sciences Latest Developments
13.3 ViiV Healthcare
13.3.1 ViiV Healthcare Company Information
13.3.2 ViiV Healthcare Rilpivirine Product Offered
13.3.3 ViiV Healthcare Rilpivirine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 ViiV Healthcare Main Business Overview
13.3.5 ViiV Healthcare Latest Developments
13.4 Strides Pharma Science Limited
13.4.1 Strides Pharma Science Limited Company Information
13.4.2 Strides Pharma Science Limited Rilpivirine Product Offered
13.4.3 Strides Pharma Science Limited Rilpivirine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Strides Pharma Science Limited Main Business Overview
13.4.5 Strides Pharma Science Limited Latest Developments
13.5 Pharmacare Limited
13.5.1 Pharmacare Limited Company Information
13.5.2 Pharmacare Limited Rilpivirine Product Offered
13.5.3 Pharmacare Limited Rilpivirine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Pharmacare Limited Main Business Overview
13.5.5 Pharmacare Limited Latest Developments
13.6 Aspen
13.6.1 Aspen Company Information
13.6.2 Aspen Rilpivirine Product Offered
13.6.3 Aspen Rilpivirine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Aspen Main Business Overview
13.6.5 Aspen Latest Developments
14 Research Findings and Conclusion
Table 1. Rilpivirine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Rilpivirine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Self-production API
Table 4. Major Players of Outsourcing of API
Table 5. Global Rilpivirine Sales by Type (2017-2022) & (K Pcs)
Table 6. Global Rilpivirine Sales Market Share by Type (2017-2022)
Table 7. Global Rilpivirine Revenue by Type (2017-2022) & ($ million)
Table 8. Global Rilpivirine Revenue Market Share by Type (2017-2022)
Table 9. Global Rilpivirine Sale Price by Type (2017-2022) & (USD/Pcs)
Table 10. Global Rilpivirine Sales by Application (2017-2022) & (K Pcs)
Table 11. Global Rilpivirine Sales Market Share by Application (2017-2022)
Table 12. Global Rilpivirine Revenue by Application (2017-2022)
Table 13. Global Rilpivirine Revenue Market Share by Application (2017-2022)
Table 14. Global Rilpivirine Sale Price by Application (2017-2022) & (USD/Pcs)
Table 15. Global Rilpivirine Sales by Company (2020-2022) & (K Pcs)
Table 16. Global Rilpivirine Sales Market Share by Company (2020-2022)
Table 17. Global Rilpivirine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Rilpivirine Revenue Market Share by Company (2020-2022)
Table 19. Global Rilpivirine Sale Price by Company (2020-2022) & (USD/Pcs)
Table 20. Key Manufacturers Rilpivirine Producing Area Distribution and Sales Area
Table 21. Players Rilpivirine Products Offered
Table 22. Rilpivirine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Rilpivirine Sales by Geographic Region (2017-2022) & (K Pcs)
Table 26. Global Rilpivirine Sales Market Share Geographic Region (2017-2022)
Table 27. Global Rilpivirine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Rilpivirine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Rilpivirine Sales by Country/Region (2017-2022) & (K Pcs)
Table 30. Global Rilpivirine Sales Market Share by Country/Region (2017-2022)
Table 31. Global Rilpivirine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Rilpivirine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Rilpivirine Sales by Country (2017-2022) & (K Pcs)
Table 34. Americas Rilpivirine Sales Market Share by Country (2017-2022)
Table 35. Americas Rilpivirine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Rilpivirine Revenue Market Share by Country (2017-2022)
Table 37. Americas Rilpivirine Sales by Type (2017-2022) & (K Pcs)
Table 38. Americas Rilpivirine Sales Market Share by Type (2017-2022)
Table 39. Americas Rilpivirine Sales by Application (2017-2022) & (K Pcs)
Table 40. Americas Rilpivirine Sales Market Share by Application (2017-2022)
Table 41. APAC Rilpivirine Sales by Region (2017-2022) & (K Pcs)
Table 42. APAC Rilpivirine Sales Market Share by Region (2017-2022)
Table 43. APAC Rilpivirine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Rilpivirine Revenue Market Share by Region (2017-2022)
Table 45. APAC Rilpivirine Sales by Type (2017-2022) & (K Pcs)
Table 46. APAC Rilpivirine Sales Market Share by Type (2017-2022)
Table 47. APAC Rilpivirine Sales by Application (2017-2022) & (K Pcs)
Table 48. APAC Rilpivirine Sales Market Share by Application (2017-2022)
Table 49. Europe Rilpivirine Sales by Country (2017-2022) & (K Pcs)
Table 50. Europe Rilpivirine Sales Market Share by Country (2017-2022)
Table 51. Europe Rilpivirine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Rilpivirine Revenue Market Share by Country (2017-2022)
Table 53. Europe Rilpivirine Sales by Type (2017-2022) & (K Pcs)
Table 54. Europe Rilpivirine Sales Market Share by Type (2017-2022)
Table 55. Europe Rilpivirine Sales by Application (2017-2022) & (K Pcs)
Table 56. Europe Rilpivirine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Rilpivirine Sales by Country (2017-2022) & (K Pcs)
Table 58. Middle East & Africa Rilpivirine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Rilpivirine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Rilpivirine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Rilpivirine Sales by Type (2017-2022) & (K Pcs)
Table 62. Middle East & Africa Rilpivirine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Rilpivirine Sales by Application (2017-2022) & (K Pcs)
Table 64. Middle East & Africa Rilpivirine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Rilpivirine
Table 66. Key Market Challenges & Risks of Rilpivirine
Table 67. Key Industry Trends of Rilpivirine
Table 68. Rilpivirine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Rilpivirine Distributors List
Table 71. Rilpivirine Customer List
Table 72. Global Rilpivirine Sales Forecast by Region (2023-2028) & (K Pcs)
Table 73. Global Rilpivirine Sales Market Forecast by Region
Table 74. Global Rilpivirine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Rilpivirine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Rilpivirine Sales Forecast by Country (2023-2028) & (K Pcs)
Table 77. Americas Rilpivirine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Rilpivirine Sales Forecast by Region (2023-2028) & (K Pcs)
Table 79. APAC Rilpivirine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Rilpivirine Sales Forecast by Country (2023-2028) & (K Pcs)
Table 81. Europe Rilpivirine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Rilpivirine Sales Forecast by Country (2023-2028) & (K Pcs)
Table 83. Middle East & Africa Rilpivirine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Rilpivirine Sales Forecast by Type (2023-2028) & (K Pcs)
Table 85. Global Rilpivirine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Rilpivirine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Rilpivirine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Rilpivirine Sales Forecast by Application (2023-2028) & (K Pcs)
Table 89. Global Rilpivirine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Rilpivirine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Rilpivirine Revenue Market Share Forecast by Application (2023-2028)
Table 92. Janssen Cilag International Basic Information, Rilpivirine Manufacturing Base, Sales Area and Its Competitors
Table 93. Janssen Cilag International Rilpivirine Product Offered
Table 94. Janssen Cilag International Rilpivirine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 95. Janssen Cilag International Main Business
Table 96. Janssen Cilag International Latest Developments
Table 97. Gilead Sciences Basic Information, Rilpivirine Manufacturing Base, Sales Area and Its Competitors
Table 98. Gilead Sciences Rilpivirine Product Offered
Table 99. Gilead Sciences Rilpivirine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 100. Gilead Sciences Main Business
Table 101. Gilead Sciences Latest Developments
Table 102. ViiV Healthcare Basic Information, Rilpivirine Manufacturing Base, Sales Area and Its Competitors
Table 103. ViiV Healthcare Rilpivirine Product Offered
Table 104. ViiV Healthcare Rilpivirine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 105. ViiV Healthcare Main Business
Table 106. ViiV Healthcare Latest Developments
Table 107. Strides Pharma Science Limited Basic Information, Rilpivirine Manufacturing Base, Sales Area and Its Competitors
Table 108. Strides Pharma Science Limited Rilpivirine Product Offered
Table 109. Strides Pharma Science Limited Rilpivirine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 110. Strides Pharma Science Limited Main Business
Table 111. Strides Pharma Science Limited Latest Developments
Table 112. Pharmacare Limited Basic Information, Rilpivirine Manufacturing Base, Sales Area and Its Competitors
Table 113. Pharmacare Limited Rilpivirine Product Offered
Table 114. Pharmacare Limited Rilpivirine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 115. Pharmacare Limited Main Business
Table 116. Pharmacare Limited Latest Developments
Table 117. Aspen Basic Information, Rilpivirine Manufacturing Base, Sales Area and Its Competitors
Table 118. Aspen Rilpivirine Product Offered
Table 119. Aspen Rilpivirine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 120. Aspen Main Business
Table 121. Aspen Latest Developments
List of Figures
Figure 1. Picture of Rilpivirine
Figure 2. Rilpivirine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rilpivirine Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Rilpivirine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Rilpivirine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Self-production API
Figure 10. Product Picture of Outsourcing of API
Figure 11. Global Rilpivirine Sales Market Share by Type in 2021
Figure 12. Global Rilpivirine Revenue Market Share by Type (2017-2022)
Figure 13. Rilpivirine Consumed in Hospital
Figure 14. Global Rilpivirine Market: Hospital (2017-2022) & (K Pcs)
Figure 15. Rilpivirine Consumed in Clinic
Figure 16. Global Rilpivirine Market: Clinic (2017-2022) & (K Pcs)
Figure 17. Rilpivirine Consumed in Drug Center
Figure 18. Global Rilpivirine Market: Drug Center (2017-2022) & (K Pcs)
Figure 19. Rilpivirine Consumed in Other
Figure 20. Global Rilpivirine Market: Other (2017-2022) & (K Pcs)
Figure 21. Global Rilpivirine Sales Market Share by Application (2017-2022)
Figure 22. Global Rilpivirine Revenue Market Share by Application in 2021
Figure 23. Rilpivirine Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Rilpivirine Revenue Market Share by Company in 2021
Figure 25. Global Rilpivirine Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Rilpivirine Revenue Market Share by Geographic Region in 2021
Figure 27. Global Rilpivirine Sales Market Share by Region (2017-2022)
Figure 28. Global Rilpivirine Revenue Market Share by Country/Region in 2021
Figure 29. Americas Rilpivirine Sales 2017-2022 (K Pcs)
Figure 30. Americas Rilpivirine Revenue 2017-2022 ($ Millions)
Figure 31. APAC Rilpivirine Sales 2017-2022 (K Pcs)
Figure 32. APAC Rilpivirine Revenue 2017-2022 ($ Millions)
Figure 33. Europe Rilpivirine Sales 2017-2022 (K Pcs)
Figure 34. Europe Rilpivirine Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Rilpivirine Sales 2017-2022 (K Pcs)
Figure 36. Middle East & Africa Rilpivirine Revenue 2017-2022 ($ Millions)
Figure 37. Americas Rilpivirine Sales Market Share by Country in 2021
Figure 38. Americas Rilpivirine Revenue Market Share by Country in 2021
Figure 39. United States Rilpivirine Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Rilpivirine Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Rilpivirine Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Rilpivirine Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Rilpivirine Sales Market Share by Region in 2021
Figure 44. APAC Rilpivirine Revenue Market Share by Regions in 2021
Figure 45. China Rilpivirine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Rilpivirine Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Rilpivirine Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Rilpivirine Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Rilpivirine Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Rilpivirine Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Rilpivirine Sales Market Share by Country in 2021
Figure 52. Europe Rilpivirine Revenue Market Share by Country in 2021
Figure 53. Germany Rilpivirine Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Rilpivirine Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Rilpivirine Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Rilpivirine Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Rilpivirine Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Rilpivirine Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Rilpivirine Revenue Market Share by Country in 2021
Figure 60. Egypt Rilpivirine Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Rilpivirine Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Rilpivirine Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Rilpivirine Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Rilpivirine Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Rilpivirine in 2021
Figure 66. Manufacturing Process Analysis of Rilpivirine
Figure 67. Industry Chain Structure of Rilpivirine
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...